Minute Insight: Indigo Diabetes Starts Human Trial Of Subcutaneous Glucose Monitor
Executive Summary
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.